Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/14635
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Instituto Nacional de Câncer José Alencar Gomes da Silva | - |
dc.contributor.author | Instituto Nacional de Câncer (Brasil) | - |
dc.contributor.author | INCA | - |
dc.date.accessioned | 2023-08-16T17:01:37Z | - |
dc.date.available | 2023-08-16T17:01:37Z | - |
dc.date.issued | 2020-10 | - |
dc.identifier.citation | INSTITUTO NACIONAL DE CÂNCER (Brasil). Notas. Rede Câncer, Rio de Janeiro, v. 46, p. 31, out. 2020 | pt_BR |
dc.identifier.uri | https://ninho.inca.gov.br/jspui/handle/123456789/14635 | - |
dc.description | p. 31.: il. color. | pt_BR |
dc.language.iso | por | pt_BR |
dc.publisher | INCA | pt_BR |
dc.subject | Neoplasias/tratamento farmacológico | pt_BR |
dc.subject | Neoplasms/drug therapy | pt_BR |
dc.subject | Neoplasias/tratamiento farmacológico | pt_BR |
dc.subject | COVID-19 | pt_BR |
dc.subject | Anti-Inflamatórios | pt_BR |
dc.subject | Anti-Inflammatory Agents | pt_BR |
dc.subject | Antiinflamatorios | pt_BR |
dc.subject | Imunoterapia | pt_BR |
dc.subject | Immunotherapy | pt_BR |
dc.subject | Inmunoterapia | pt_BR |
dc.title | Notas | pt_BR |
dc.title.alternative | Rede Câncer 46 | pt_BR |
dc.Type | Article | pt_BR |
Appears in Collections: | Rede Câncer 46 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.